TSLP and Alzheimer disease: Immune dysregulation in AD is characterized by a dominant Th2 axis involving cytokines such as IL-4, IL-13, IL-5, thymic stromal lymphopoietin (TSLP), and IL-31, along with elevated Th17/IL-23 pathways and increased IgE levels [103].